2018 July e-NEWS
MESSAGE FROM THE EXECUTIVE DIRECTOR
We’ve had a banner first-half, thanks to you!
As we move past the “half year” mark and ease into summer mode, it’s good to pause and reflect on the work we’ve done, and how much we’ve accomplished. Thanks to you, we’ve accomplished a lot. Our fiscal year ended March 31, and I’m pleased to report that it was a great year for revenue—we came in $300,000 over our projected goal! We had an incredibly fun and successful Pink Tie Party. And nearly 2,500 of you came together in solidarity to run, walk, celebrate and participate at our 11th Annual Race for the Cure. So much of our success is due to the friendship and dedication of people like you who continue to support our mission.
Most of the money we raise (with your help) goes to fund grants to local community non-profits who provide breast health/breast cancer education, screening and diagnostic tests, treatment support and survivorship programs to underserved women and men in our nine North Jersey counties. We are very proud of the fact that this year we were able to increase our grant funding by 15%. As a matter of fact, for the past six years, we have had strong and steady growth—since 2012, we have increased our grant funding by 78%. We’re making a bigger difference, and we couldn’t do it without you.
I have no doubt that together we WILL put an end to breast cancer. From all of us at Komen North Jersey, THANK YOU for your loyalty and generosity. Wishing you a wonderful, happy and healthy summer!
With deep appreciation,
Kelly E. Nagle
FOCUS ON RESEARCH
In June, the New England Journal of Medicine published the findings of the TAILORx study (Trial Assigning Individualized Options for Treatment), a landmark trial that showed that some women with early stage breast cancer may not need to undergo chemotherapy treatment. The work of the lead physician in this study, Dr. Joseph A. Sparano, was funded by Susan G. Komen. Dr. Sparano is the Associate Director for Clinical Research at the Albert Einstein Cancer Center and Montefiore Health System in New York City and Vice Chair of the ECOG-ACRIN Cancer Research Group.
“The new results from TAILORx give clinicians high-quality data to inform personalized treatment recommendations for women,” said Dr. Sparano. “These data confirm that using a 21-gene expression test to assess the risk of cancer recurrence can spare women unnecessary treatment if the test indicates that chemotherapy is not likely to provide benefit.”
The study found that 70 percent of women with early stage breast cancers that are HER2 negative, sensitive to estrogen (HR positive) and axillary lymph node–negative may be able to forego chemotherapy and its toxic side effects. By using individuals’ Oncotype DX Genomic testing score, researchers found that some patients need take only hormone therapy, drugs that block the hormone estrogen or stops the body from making it.
Susan G. Komen has invested more than $266 million in over 590 research grants and nearly 100 clinical trials focused on the field of precision medicine (sometimes called “personalized” medicine). Precision medicine refers to the tailoring of medical treatment to the individual characteristics of each patient using both genetic and clinical information (including the use of biomarkers) to make accurate predictions about a person’s susceptibility of developing disease, the course of disease, and its response to treatment. The TAILORx study is part of a wider effort to fine-tune treatments and spare patients from harsh side effects whenever possible.
Komen North Jersey awarded a total of 13 grants to 11 local community non-profit organizations in its nine-county service area for 2018-2019, with an increase in total program funding at 15% year over year. In addition, this year, we have set aside $10,000 to fund a special grant devoted to providing support to breast cancer survivors. Since our founding in 1997, our Affiliate has awarded nearly $19 million in grants to local community programs in nine North Jersey counties and has directed more than $7 million to national research initiatives in pursuit of new breast cancer screening techniques, better and more effective treatment options, and ultimately, the causes and cures to eradicate breast cancer forever.
The 2018-2019 Komen North Jersey Grantee organizations include: Bergen Volunteer Medical Initiative, Breast Cancer Emergency Aid Foundation, Cancer Care, Clara Maass Medical Center, Englewood Medical Center, Hoboken Family Planning, Newark Beth Israel Medical Center, Northwest Jersey Community Action Partnership, Inc., Overlook Medical Center, Somerset Health Care Foundation and Trinitas Regional Medical Center.
IT’S A WRAP
This year’s major events, Pink Tie Party and Race for the Cure, raised the bar for fundraising and “major” good times!
We certainly took a “bold leap forward” at our Pink Tie Party, garnering nearly $400,000 in support of our BOLD GOAL to reduce the number of breast cancer deaths in the U.S. by 50% by the year 2026. More than 300 people joined us on March 16th at The Grove in Cedar Grove for a fabulous evening co-chaired by Michele Caselnova, President, Komen North Jersey Board of Directors; Tim Harbison, Director, Komen North Jersey Board; and Connie Harbison.
Special thanks to this year’s Pink Tie Party sponsors: Dun & Bradstreet and TAPinto (Funding the Cures); Horizon Blue Cross Blue Shield of New Jersey, NJM Insurance Group, Pfizer, and RWJBarnabas Health (Partners in the Promise); Atlantic Health System, BD, The Harbison Family, Novartis, Inserra Supermarkets Inc., Tito’s Handmade Vodka, and Wakefern Food Corp. (Pledging Hope); Brother, CarePoint Health, East Coast Advanced Plastic Surgery, Hackensack Meridian Health, NASCO, NJBIZ, NJ Sharing Network, Summit Medical Group/Summit Health Management, Tiffany & Co., and Village Supermarket (Making an Impact).
We challenged you to BE BOLD. BE FEARLESS. BE MORE (THAN PINK). And you didn’t let us down—more than 2,500 of you (including hundreds of survivors and forever fighters!) came out to join us for our 11th Annual Race for the Cure held on Sunday, May 6th at Liberty State Park in Jersey City. The event, locally presented by ShopRite and Xfinity and led by Honorary Race Chair Mayor Steven Fulop of Jersey City, raised $600,000 for the fight against breast cancer. We couldn’t have done it without your help! Congratulations to our top Race fundraisers: Gloria Feiner, Individual Division; For My Daughter, Top Overall and Corporate Division; Suzanne’s Breast Friends, Friends & Family Division; and Summit Medical Group MD Anderson Breast Care Center, Healthcare Division.
And what a good time we had! The weather stayed dry (phew!) and the day was chock full of activities. The race course for our USATF Certified 5K Timed Run and 5K Fun Walk provided spectacular views of the Jersey City skyline, the Statue of Liberty and of course, the Hudson River. Survivors were welcomed in our beautiful, exclusive Survivor Tent, and enjoyed a hot breakfast compliments of ShopRite; mini-makeovers; door prizes; giveaways; special commemorative Survivor and Forever Fighter Medals; and more. Special thanks to our Local Survivor Sponsor RWJBarnabas Health and to our Survivor Tent décor designer, Komen Volunteer Judy Swajger. For the kids, we had a fun (and educational) Scavenger Hunt (with prizes, of course), face painting, and “bear hugs” from our favorite Pink Care Bear. The Wellness Village sponsored by CarePoint Health offered a wealth of health and wellness information and lots of great giveaways, and the Komen Moment Photo Tent sponsored by TAPinto was a real hot spot this year.
Huge thanks to WABC-TV Eyewitness News reporter Anthony Johnson who does such a wonderful job as our Master of Ceremonies; the adorable and energetic Liberty All-Stars Cheerleaders; and to the very talented musicians who donated their services to provide us with wonderful music throughout our Race Day: Soprano Marny Hughes (“America the Beautiful”); our fabulous band Running Late (with a nod to lead singer Lauren D’Imperio for “The Star-Spangled Banner”); and the beautiful voices of The Dominoes from St. Dominic Academy in Jersey City (Survivor Procession & Ceremony).
We are very grateful for the generosity of our 2018 Race for the Cure Sponsors:
Local Presenting Sponsors ShopRite and Xfinity; Platinum Sponsor/Komen Moment Photo Tent Sponsor TAPinto, Local Survivor Sponsor RWJBarnabas Health; Official Transportation Sponsor NY Waterway; Wellness Village Sponsor CarePoint Health; Gold Sponsors BERGEN Magazine and Morris/Essex Health & Life; Silver Sponsors Atlantic Health System, BD, Eight O’ Clock Coffee, Horizon Blue Cross Blue Shield of New Jersey, NJ.com/The Star-Ledger and PSE&G; Bronze Sponsors Newport Centre-a Simon Mall, Novartis and Pfizer; Official Team Sponsor RPM Raceway, Social Media Sponsor Summit Medical Group MD Anderson Cancer Center; Komen Friend Sponsors BASF, Boston Barricade, City of Jersey City, East Coast Advanced Plastic Surgery, Edelson Communications, LLC, Eloquent Studios, Joe’s Crab Shack of Edgewater, NJ Monthly, NJ Transit, NJ Transit Police, Outfront Media, and WellCare Health Plans.
Mary Anne Byer, 1955-2018
We are deeply saddened by the passing of Komen North Jersey volunteer Mary Byer on May 30, 2018 at the age of 62. In the early days of the Affiliate, Mary, a registered nurse and Health Officer for three local towns, , applied for a Komen North Jersey grant through her Health Department to expand their breast screening and education program. We visited the site and became acquainted with Mary and her community work. She was very interested in Komen North Jersey and our work. When she took time off from work to be with her four high school teenagers, we invited her to be on our Grant Committee.
Years later, after she went back to work at Kessler, she began asking questions about the Komen National Research Program. National was always asking for volunteers from the Affiliates to review grants, and we submitted Mary’s name and credentials. She was approved, went for reviewer training, and served for several years. Incredibly, when Mary was going through treatment, she recognized a drug that had come out of a clinical trial that she had reviewed.
Those who knew Mary well describe her as one of the smartest, most dedicated health care professionals, with profound intuition, kindness and caring which she shared with all who crossed her life. Rest in peace, Mary; you will forever be remembered and missed for all you did for us, for all…
SAVE THE DATES
Make sure to mark the dates on your calendar for our exciting events for 2018-2019!
SATURDAY, SEPTEMBER 29, 2018
Women’s Wellness Expo
Passaic County Technical Institute, Wayne
FRIDAY, MARCH 22, 2019
The Pink Tie Party
The Grove, Cedar Grove
SUNDAY, MAY 5, 2019
Komen North Jersey Race for the Cure
Liberty State Park, Jersey City
BE A DEAR, VOLUNTEER
We invite you to join the Komen North Jersey Volunteer Team!
Our volunteers play a vital role in Komen North Jersey’s mission. Their passion and commitment contribute greatly to our success. Besides getting that “feel good” feeling that you’re making a difference, volunteering is fun; it’s rewarding; and you’ll meet some truly incredible people. People like you who believe in giving back, and who are dedicated to the fight against breast cancer.
We need hardworking, dedicated (and fun-loving) people for a variety of tasks, including office and administrative work, assistance at (and before) our major events, and more. We have a variety of assignments to match your schedule, skills and preferences—we want to make sure that you truly enjoy the experience of helping us save lives in our communities.
If you are interested in volunteering, contact Gail Ransom Brown, Special Event & Volunteer Coordinator at email@example.com or (908) 277-2904, ext. 212.
Thank you to our National Apparel and Footwear Sponsor New Balance for “Putting their Feet in the Fight” to end breast cancer. Gear up with the Lace Up for the Cure® Collection and 5% of your purchase benefits Susan G. Komen.
We would like to thank our 2018 Affiliate Sponsors for their continuing commitment to Komen North Jersey and the fight against breast cancer: